Petrović R M, Jokanović M, Maksimović M, Ugresić N, Bosković B
Pharmazie. 2000 Jun;55(6):454-5.
This study was undertaken to examine the influence of atropine, oximes and benzodiazepine on organophosphate-induced delayed polyneuropathy (OPIDP) in hens, which were poisoned with diisopropylfluorophosphate (DFP). The birds were treated with a standard neuropathic dose of DFP (1.1 mg/kg, s.c.), which produced typical signs of OPIDP. The development of OPIDP was observed within the followings 22 days. All drugs were given subcutaneously (s.c.), intramuscularly (i.m.) or intraperitoneally (i.p.), 20 min before the poison. The results obtained have shown that atropine (20 mg/kg, i.p.) only in combination with oxime TMB-4 (15 mg/kg, i.m.) produced significant improvement of OPIDP symptoms in comparison with positive control. Clinical signs and symptoms of OPIDP in the group which was treated with atropine (20 mg/kg, i.p.), TMB-4 (15 mg/kg, i.m.) and midazolam (2.5 mg/kg, i.m.) were more improved than that in the presence of a combination of atropine and TMB-4. The results of these experiments have shown that it is possible to prevent the development of DFP-induced OPIDP in hens by treatment with atropine and TMB-4 or atropine, TMB-4 and midazolam when given before DFP.
本研究旨在考察阿托品、肟类化合物和苯二氮䓬类药物对二异丙基氟磷酸酯(DFP)中毒母鸡的有机磷诱导迟发性多神经病(OPIDP)的影响。给这些鸟注射标准的致神经病剂量的DFP(1.1毫克/千克,皮下注射),其产生了OPIDP的典型症状。在接下来的22天内观察OPIDP的发展情况。所有药物均在中毒前20分钟皮下注射(s.c.)、肌肉注射(i.m.)或腹腔注射(i.p.)。所得结果表明,与阳性对照相比,仅阿托品(20毫克/千克,腹腔注射)与肟类化合物TMB - 4(15毫克/千克,肌肉注射)联合使用时能显著改善OPIDP症状。用阿托品(20毫克/千克,腹腔注射)、TMB - 4(15毫克/千克,肌肉注射)和咪达唑仑(2.5毫克/千克,肌肉注射)治疗的组中OPIDP的临床体征和症状比阿托品和TMB - 4联合使用时改善得更明显。这些实验结果表明,在DFP给药前用阿托品和TMB - 4或阿托品、TMB - 4和咪达唑仑治疗,有可能预防母鸡发生DFP诱导的OPIDP。